Literature DB >> 921318

Serum complement depression during viral lower respiratory tract illness in cystic fibrosis.

R C Strunk, O F Sieber, L M Taussig, E P Gall.   

Abstract

Cystic fibrosis (CF) patients with viral lower respiratory tract illnesses (LRI) had depressed levels of the third and fourth components of complement, which returned to normal after recovery. There was no clinical evidence of immune complex disease. CF patients with LRI and no virus isolates, CF patients in stable status, and non-CF patients with LRI did not have complement depression. It is postulated that antigen-antibody complex activation of complement may occur in CF patients with viral LRI.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 921318      PMCID: PMC1544734          DOI: 10.1136/adc.52.9.687

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

1.  Immune complexes in cystic fibrosis.

Authors:  H McFarlane; A Holzel; P Brenchley; J D Allan; J C Wallwork; B E Singer; B Worsley
Journal:  Br Med J       Date:  1975-02-22

2.  SPECIFIC ISOANTIBODIES IN CYSTIC FIBROSIS. A STUDY OF SERUM AND BRONCHIAL MUCUS.

Authors:  A A STEIN; F C MANLAPAS; K F SOIKE; P R PATTERSON
Journal:  J Pediatr       Date:  1964-10       Impact factor: 4.406

Review 3.  Virus neutralization and virus-induced immune complex disease. Virus-antibody union resulting in immunoprotection or immunologic injury--two sides of the same coin.

Authors:  M B Oldstone
Journal:  Prog Med Virol       Date:  1975

Review 4.  Cystic fibrosis: current concepts.

Authors:  M J Polley; A G Bearn
Journal:  J Med Genet       Date:  1974-09       Impact factor: 6.318

5.  Letter: Complement components in cystic fibrosis.

Authors:  S Hann; D S Holsclaw; H S Shin
Journal:  Lancet       Date:  1974-08-31       Impact factor: 79.321

6.  Letter: Complement components in cystic fibrosis.

Authors:  J H Conover; E J Conod; K Hirschhorn
Journal:  Lancet       Date:  1973-12-29       Impact factor: 79.321

7.  A new prognostic score and clinical evaluation system for cystic fibrosis.

Authors:  L M Taussig; J Kattwinkel; W T Friedewald; P A Di Sant'Agnese
Journal:  J Pediatr       Date:  1973-03       Impact factor: 4.406

8.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

9.  Some aspects of immunity in patients with cystic fibrosis.

Authors:  J C Wallwork; P Brenchley; J McCarthy; J D Allan; D Moss; A M Ward; A Holzel; R F Williams; H McFarlane
Journal:  Clin Exp Immunol       Date:  1974-11       Impact factor: 4.330

10.  A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement.

Authors:  T A Gaither; D W Alling; M M Frank
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

  10 in total
  3 in total

Review 1.  Spectrum of viral infections in patients with cystic fibrosis.

Authors:  H Frickmann; S Jungblut; T O Hirche; U Groß; M Kuhns; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

2.  Serum complement components in patients with trachoma.

Authors:  D K Sen; G S Sarin; M Hiranandani; U K Baveja
Journal:  Br J Ophthalmol       Date:  1985-09       Impact factor: 4.638

3.  Serum complement component depression during acute adenovirus conjunctivitis.

Authors:  A K Gupta; G S Sarin
Journal:  Br J Ophthalmol       Date:  1984-05       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.